SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 132 filers reported holding SERES THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $256,117 | -43.5% | 107,612 | +34.5% | 0.00% | -50.0% |
| Q1 2023 | $453,600 | +41.3% | 80,000 | +60.0% | 0.01% | +100.0% |
| Q3 2022 | $321,000 | +86.6% | 50,000 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $172,000 | -90.3% | 50,000 | -80.0% | 0.00% | -90.9% |
| Q1 2022 | $1,780,000 | +249.0% | 250,000 | +241.3% | 0.02% | +266.7% |
| Q3 2021 | $510,000 | -91.5% | 73,250 | -70.7% | 0.01% | -92.3% |
| Q2 2021 | $5,965,000 | +428.3% | 250,136 | +356.5% | 0.08% | +225.0% |
| Q1 2021 | $1,129,000 | -88.2% | 54,800 | -83.8% | 0.02% | -89.3% |
| Q3 2020 | $9,572,000 | +4911.5% | 338,100 | +745.2% | 0.22% | +3633.3% |
| Q2 2020 | $191,000 | – | 40,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 23,117,045 | $110,730,646 | 4.94% |
| Lion Point Capital, LP | 691,803 | $3,313,736 | 1.50% |
| Eversept Partners, LP | 3,076,756 | $14,737,661 | 1.23% |
| Soleus Capital Management, L.P. | 2,045,983 | $9,800,259 | 1.09% |
| Knott David M Jr | 470,000 | $2,251 | 0.90% |
| GREAT POINT PARTNERS LLC | 938,067 | $4,493,341 | 0.88% |
| Simplify Asset Management Inc. | 550,626 | $2,637,499 | 0.35% |
| Delphia (USA) Inc. | 33,913 | $162,443 | 0.26% |
| Alpha DNA Investment Management LLC | 138,536 | $663,587 | 0.22% |
| Avoro Capital Advisors LLC | 2,500,000 | $11,975,000 | 0.16% |